Dual Immunization Against RSV With RSVpreF and Nirsevimab
JAMA Pediatrics · 01.08.2026 · 180 (8) · 900
DOI: 10.1001/jamapediatrics.2026.1346 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Pediatrics, erschienen am 01.08.2026. Verfasst von Ludovic Tréluyer und 7 weiteren Autor:innen. Beteiligte Einrichtung: French National Agency for Medicines and Health Products Safety and French National Health Insurance, Saint-Denis, France. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cohort study aimed to describe RSV-associated lower respiratory tract infection hospitalizations among infants in France who received both maternal RSV-preF vaccination and nirsevimab during the 2024-2025 RSV season.
Autor:innen und Institutionen
- French National Agency for Medicines and Health Products Safety and French National Health Insurance, Saint-Denis, France.
Zitieren
APA
Tréluyer, L., Bertrand, M., Gabet, A., Jabagi, M. J., Kolla, E., Olié, V., Zureik, M., & Rachas, A. (2026). Dual Immunization Against RSV With RSVpreF and Nirsevimab. JAMA Pediatrics, 180(8), 900. https://doi.org/10.1001/jamapediatrics.2026.1346
Vancouver
Tréluyer L, Bertrand M, Gabet A, Jabagi MJ, Kolla E, Olié V, et al. Dual Immunization Against RSV With RSVpreF and Nirsevimab. JAMA Pediatrics. 2026;180(8):900. doi:10.1001/jamapediatrics.2026.1346
BibTeX
@article{Trluyer2026,
author = {Tréluyer, Ludovic and Bertrand, Marion and Gabet, Amélie and Jabagi, Marie-Joelle and Kolla, Epiphane and Olié, Valérie and Zureik, Mahmoud and Rachas, Antoine},
title = {Dual Immunization Against RSV With RSVpreF and Nirsevimab},
journal = {JAMA Pediatrics},
year = {2026},
volume = {180},
number = {8},
pages = {900},
doi = {10.1001/jamapediatrics.2026.1346}
}
EUVIMED